MaxLife review

What it is

MaxLife Technologies Inc. describes itself as a patient management platform that works with independent physicians and practitioners; its terms also refer to affiliated medical groups, and they make clear that the company itself is not a healthcare provider. The FDA letter addresses it at an office in Irvine, California, and its terms are governed by California law, with disputes sent to individual arbitration in Irvine. It sells only two treatments, compounded semaglutide and compounded tirzepatide, and says it serves all 50 states. The homepage cites more than 15,000 members, rotating testimonials and before-and-after figures, and plans are described as FSA and HSA eligible, subject to your plan's rules. It doesn't take insurance. The site shows a LegitScript badge that links to LegitScript's checker, but no seal number, so look the company up on LegitScript yourself if certification matters to you.

How it works

You start with an online intake that takes about five minutes. A provider reviews it, usually within 24 hours, and if your state requires a live televisit, a licensed provider contacts you to schedule a two-way audio and video appointment; elsewhere the review is asynchronous. If you're approved, the prescription goes to a licensed partner pharmacy in your state, which typically takes two to three business days to process and ship. Medication and needles arrive in an insulated, iced container that can stay in the box for up to 72 hours. Depending on your billing period, shipments come monthly or every 90 days. After that you can message your provider for dose changes and side-effect help. If you think you need a higher dose, the team arranges a call with a provider to review it. The site also offers a free 20-minute phone consultation with its weight-loss team before you sign up.

Pricing transparency

Each plan page shows two options. The Monthly Plan is $155 a month for semaglutide and $195 for tirzepatide, which MaxLife calls a guaranteed fee. The Starter Kit is a three-month bundle billed up front, $267 for semaglutide ($89 a month) or $360 for tirzepatide ($120 a month), after which you move to the monthly rate. The homepage's "starting at" prices are the Starter Kit figures. The membership covers the medication, supplies, prescriber and priority shipping; there are no separate consultation fees. Two caveats. First, the FAQ says that if a higher dose is approved, your prescription and membership will be adjusted accordingly, so ask what the fee becomes at each dose. Second, the site promises a free consultation with no upfront payment, while the Starter Kit is billed at the start, so check when the first charge lands. Subscriptions renew automatically. To cancel you must email the company at least 30 days before the date you want the cancellation to take effect; payments aren't refunded and there's no credit for partial periods, though you keep access through the paid period. If you're found ineligible, you're refunded. Plans with a preset commitment carry an early termination fee set out in the plan offer. Shipped items can't be returned. The site also advertises a six-month results guarantee and a price-match guarantee, but the plan pages and terms don't spell out their conditions.

Branded vs compounded

Compounded semaglutide and compounded tirzepatide, both weekly injections. The FAQ says some formulations may include B vitamins or glycine, depending on the pharmacy, and that results from the brand-name trials (STEP 1 for Wegovy, SURMOUNT-3 for Zepbound) haven't been established for compounded versions. MaxLife names the pharmacies that may fill your order: its homepage lists Dirx, Southend, Hallandale, Red Rock, Advanced, Perfect Rx, Health Wealth, Quaker Community, VLS and NewLife Rx, and the semaglutide page names Hallandale, Red Rock and Strive. The one you get depends on your state and availability. No brand-name GLP-1 is sold. In February 2026 the FDA sent MaxLife a warning letter after reviewing its website in December 2025. The agency said product images labeled "Maxlife" suggested the company was the compounder when it is not, and cited claims such as "generic compounded medication" and "FDA Approved" that implied FDA approval. The site today carries a statement that compounded medications aren't FDA-approved. The letter is disclosed and linked on this page.

Pros and watch-outs

The evidence behind what MaxLife prescribes

We grade the molecules, not the marketing. Here is what the human data actually shows for each thing on their menu.

• What the semaglutide weight-loss trials actually showed

  STEP 1, STEP 4, and SELECT — the efficacy, the rebound, and the cardiovascular signal, read straight from the primary literature.

• Tirzepatide vs semaglutide for weight loss: what the trials actually support

  Most comparisons are cross-trial. Only SURPASS-2 and SURMOUNT-5 randomized one drug against the other — here's the precise distinction.

• Compounded vs branded GLP-1: regulatory status, sourcing and the evidence

  Compounded GLP-1 isn't FDA-approved, the shortage exception behind it ended in 2025, the FDA moved against mass-marketed copies in 2026, and the trial data belong to the branded product. Here's the precise picture.

How MaxLife compares

A few alternatives worth a look, depending on what you’re optimizing for.

• Direct Meds

  Straightforward compounded GLP-1 without an insurance requirement

  See Direct Meds →
• Strut Health

  A general telehealth that covers GLP-1 alongside other everyday care

  See Strut Health →
• Mint Med

  Buyers in its 36 listed states who want a low month-to-month compounded price at every dose with no membership

  See Mint Med →

More GLP-1 telehealth reviews: Amble · knownwell · Measured · Calibrate · Alan Meds · Aspen